Deep Tech Capital Movements Vol. 7
Weekly tracking of funding rounds, new funds, and strategic shifts in deep tech.
Welcome back to Deep Tech Capital Moments! Every week, we track funding rounds, new funds, and major strategic moves in deep tech—helping you to:
Spot the next big deal before it goes mainstream.
Benchmark your investments against the latest trends.
Track your competition.
Identify emerging trends before they become obvious.
See who’s backing what—and why.
If you’re building, investing, or betting on deep tech, this is for you!
💡 Got a big deal to share? If your fund just backed something game-changing—or your startup just raised—let’s make sure the right people see it.
✨ For more, see Membership | Partnership | DeepTech Catalyst | DeepTech Briefing
✨Deep Tech Capital Movements is just one part of The Scenarionist experience. To enjoy the full experience, become a Premium Member.
The Scenarionist Premium is your exclusive access to strategies, insights, and tactics designed for those who build, invest, and innovate in Deep Tech.
Startups Funding Updates
🔸 Fuse Vectors Secures €4.9M for Cell-Free Gene Therapy Innovation
Copenhagen-based Fuse Vectors secured €4.9M in pre-seed funding to scale its novel cell-free viral vector technology for gene therapy. The round was backed by HCVC, BioInnovation Institute, EIFO, and Innovation Fund. Fuse Vectors’ approach eliminates cell-based production bottlenecks, reducing costs and improving efficiency in AAV vector manufacturing.
Deal: Pre-Seed Round